| Case fatality rates of invasive meningococcal disease by serogroup and age: a systematic review and meta-analysis B Wang, R Santoreneos, L Giles, HHA Afzali, H Marshall Vaccine 37 (21), 2768-2782, 2019 | 146 | 2019 |
| Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme: an observational … B Wang, L Giles, P Andraweera, M McMillan, S Almond, R Beazley, ... The Lancet Infectious Diseases 22 (7), 1011-1020, 2022 | 53 | 2022 |
| The inpatient costs and hospital service use associated with invasive meningococcal disease in South Australian children B Wang, HHA Afzali, H Marshall Vaccine 32 (37), 4791-4798, 2014 | 36 | 2014 |
| A systematic review and meta-analysis on the real-world effectiveness of COVID-19 vaccines against infection, symptomatic and severe COVID-19 disease caused by the omicron … H Mohammed, DD Pham-Tran, ZYM Yeoh, B Wang, M McMillan, ... Vaccines 11 (2), 224, 2023 | 32 | 2023 |
| The clinical burden and predictors of sequelae following invasive meningococcal disease in Australian children B Wang, M Clarke, N Thomas, S Howell, HHA Afzali, H Marshall The Pediatric infectious disease journal 33 (3), 316-318, 2014 | 32 | 2014 |
| Community, parental and adolescent awareness and knowledge of meningococcal disease B Wang, M Clarke, HHA Afzali, H Marshall Vaccine 32 (18), 2042-2049, 2014 | 31 | 2014 |
| Impact of meningococcal B vaccine on invasive meningococcal disease in adolescents M McMillan, B Wang, AP Koehler, TR Sullivan, HS Marshall Clinical Infectious Diseases 73 (1), e233-e237, 2021 | 27 | 2021 |
| Asymptomatic SARS-CoV-2 infection by age: a global systematic review and meta-analysis B Wang, P Andraweera, S Elliott, H Mohammed, Z Lassi, A Twigger, ... The Pediatric Infectious Disease Journal 42 (3), 232-239, 2023 | 25 | 2023 |
| Costs of invasive meningococcal disease: a global systematic review B Wang, R Santoreneos, H Afzali, L Giles, H Marshall PharmacoEconomics 36, 1201-1222, 2018 | 23 | 2018 |
| Increased cardiomyocyte alignment and intracellular calcium transients using micropatterned and drug-releasing poly (glycerol sebacate) elastomers C Zhu, AE Rodda, VX Truong, Y Shi, K Zhou, JM Haynes, B Wang, ... ACS Biomaterials Science & Engineering 4 (7), 2494-2504, 2018 | 22 | 2018 |
| Adolescent confidence in immunisation: assessing and comparing attitudes of adolescents and adults B Wang, L Giles, HHA Afzali, M Clarke, J Ratcliffe, G Chen, H Marshall Vaccine 34 (46), 5595-5603, 2016 | 22 | 2016 |
| Adolescent values for immunisation programs in Australia: a discrete choice experiment B Wang, G Chen, J Ratcliffe, HHA Afzali, L Giles, H Marshall PLoS One 12 (7), e0181073, 2017 | 21 | 2017 |
| COVID-19 immunisation, willingness to be vaccinated and vaccination strategies to improve vaccine uptake in Australia B Wang, R Nolan, H Marshall Vaccines 9 (12), 1467, 2021 | 19 | 2021 |
| Safety of meningococcal B vaccine (4CMenB) in adolescents in Australia HS Marshall, AP Koehler, B Wang, M A'Houre, M Gold, H Quinn, ... Vaccine 38 (37), 5914-5922, 2020 | 16 | 2020 |
| 4CMenB sustained vaccine effectiveness against invasive meningococcal B disease and gonorrhoea at three years post programme implementation B Wang, L Giles, P Andraweera, M McMillan, S Almond, R Beazley, ... Journal of Infection 87 (2), 95-102, 2023 | 12 | 2023 |
| Evaluating the effectiveness of the 4CMenB vaccine against invasive meningococcal disease and gonorrhoea in an infant, child and adolescent program: protocol HS Marshall, PH Andraweera, B Wang, M McMillan, AP Koehler, N Lally, ... Human Vaccines & Immunotherapeutics 17 (5), 1450-1454, 2021 | 12 | 2021 |
| Control of invasive meningococcal disease: is it achievable? H Marshall, B Wang, S Wesselingh, M Snape, AJ Pollard JBI Evidence Implementation 14 (1), 3-14, 2016 | 11 | 2016 |
| COVID-19 vaccine willingness prior to and during the COVID-19 vaccination rollout in Australia B Wang, R Nolan, B Krumeich, K D’Onise, H Marshall Human Vaccines & Immunotherapeutics 18 (5), 2079345, 2022 | 9 | 2022 |
| Lifetime costs of invasive meningococcal disease: a Markov model approach B Wang, HHA Afzali, L Giles, H Marshall Vaccine 37 (46), 6885-6893, 2019 | 9 | 2019 |
| Asymptomatic SARS-CoV-2 infection by age: A systematic review and meta-analysis B Wang, P Andraweera, S Elliott, H Mohammed, Z Lassi, A Twigger, ... medRxiv, 2022.05. 05.22274697, 2022 | 3 | 2022 |
Helen MarshallUniversity of AdelaideVerified email at adelaide.edu.au
